ATE238417T1
(de)
|
1991-11-04 |
2003-05-15 |
Inst Genetics Llc |
Rekombinante knochenmorphogenetische protein heterodimere, zusammensetzungen und verfahren zur verwendung
|
US20030074680A1
(en)
*
|
1993-03-19 |
2003-04-17 |
Johns Hopkins University School Of Medicine |
Growth differentiation factor-8
|
US5994618A
(en)
|
1997-02-05 |
1999-11-30 |
Johns Hopkins University School Of Medicine |
Growth differentiation factor-8 transgenic mice
|
US6607884B1
(en)
|
1993-03-19 |
2003-08-19 |
The Johns Hopkins University School Of Medicine |
Methods of detecting growth differentiation factor-8
|
US7393682B1
(en)
*
|
1993-03-19 |
2008-07-01 |
The Johns Hopkins University School Of Medicine |
Polynucleotides encoding promyostatin polypeptides
|
JPH09507829A
(ja)
|
1993-03-19 |
1997-08-12 |
ジョーンズ ホプキンス ユニバーシティー スクール オブ メディシン |
増殖分化因子−8
|
US7566768B1
(en)
|
1995-10-26 |
2009-07-28 |
The Johns Hopkins University School Of Medicine |
Promyostatin peptides and methods of using same
|
US6465239B1
(en)
|
1993-03-19 |
2002-10-15 |
The John Hopkins University School Of Medicine |
Growth differentiation factor-8 nucleic acid and polypeptides from aquatic species and non-human transgenic aquatic species
|
EP2272959A1
(de)
*
|
1993-05-12 |
2011-01-12 |
Genetics Institute, LLC |
BMP-11 Zusammenstellungen
|
US6713302B1
(en)
*
|
1993-07-09 |
2004-03-30 |
The Johns Hopkins University School Of Medicine |
Growth differentiation factor-6
|
US7332575B2
(en)
|
1994-03-18 |
2008-02-19 |
The Johns Hopkins University School Of Medicine |
Growth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species
|
US6008434A
(en)
|
1994-07-08 |
1999-12-28 |
Johns Hopkins University School Of Medicine |
Growth differentiation factor-11 transgenic mice
|
CA2194660C
(en)
*
|
1994-07-08 |
2009-09-29 |
Se-Jin Lee |
Growth differentiation factor-11
|
US20030167492A1
(en)
|
1994-07-08 |
2003-09-04 |
Johns Hopkins University School Of Medicine |
Transgenic non-human animals expressing a gdf-11 dominant negative polypeptide, and methods of making and using same
|
US5846770A
(en)
*
|
1994-11-22 |
1998-12-08 |
Genetics Institute, Inc. |
DNA molecules encoding human chordin
|
US5635372A
(en)
*
|
1995-05-18 |
1997-06-03 |
Genetics Institute, Inc. |
BMP-15 compositions
|
CA2220555C
(en)
|
1995-06-05 |
2011-07-19 |
John M. Wozney |
Methods and compositions for healing and repair of connective tissue attachment
|
US5700774A
(en)
*
|
1996-03-26 |
1997-12-23 |
Genetics Institute, Inc. |
Compositions comprising bone morphogenic proteins and truncated parathyroid hormone related peptide, and methods of inducing cartilage by administration of same
|
US5965403A
(en)
*
|
1996-09-18 |
1999-10-12 |
Genetics Institute, Inc. |
Nucleic acids encoding bone morphogenic protein-16 (BMP-16)
|
US7041641B2
(en)
|
1997-03-20 |
2006-05-09 |
Stryker Corporation |
Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects
|
US20010016646A1
(en)
|
1998-03-20 |
2001-08-23 |
David C. Rueger |
Osteogenic devices and methods of use thereof for repair of endochondral bone, osteochondral and chondral defects
|
EP0985149A1
(de)
|
1997-05-30 |
2000-03-15 |
Creative Biomolecules, Inc. |
Verfahren zur bestimmung der gewebemorphogenese und morphogenesische tätigkeit
|
US20070067859A1
(en)
*
|
1997-07-14 |
2007-03-22 |
Michel Georges |
Double-muscling in mammals
|
PT2045322E
(pt)
*
|
1997-07-14 |
2015-10-16 |
Université de Liège |
Musculatura dupla em mamíferos
|
US6103466A
(en)
*
|
1997-07-14 |
2000-08-15 |
University Of Liege |
Double-muscling in mammals
|
US6656475B1
(en)
|
1997-08-01 |
2003-12-02 |
The Johns Hopkins University School Of Medicine |
Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same
|
US6891082B2
(en)
*
|
1997-08-01 |
2005-05-10 |
The Johns Hopkins University School Of Medicine |
Transgenic non-human animals expressing a truncated activintype II receptor
|
US6696260B1
(en)
*
|
1997-08-01 |
2004-02-24 |
The Johns Hopkins University School Of Medicine |
Methods to identify growth differentiation factor (GDF) binding proteins
|
US20020052026A1
(en)
|
1997-10-08 |
2002-05-02 |
Steven M. Vicik |
Methods of refolding proteins
|
US6027917A
(en)
*
|
1997-12-10 |
2000-02-22 |
Genetics Institute, Inc. |
Bone morphogenetic protein (BMP)-17 and BMP-18 compositions
|
CA2319703C
(en)
*
|
1998-02-05 |
2005-09-20 |
The Johns Hopkins University School Of Medicine |
Growth differentiation factor-8
|
US6369201B1
(en)
*
|
1998-02-19 |
2002-04-09 |
Metamorphix International, Inc. |
Myostatin multimers
|
US6004937A
(en)
*
|
1998-03-09 |
1999-12-21 |
Genetics Institute, Inc. |
Use of follistatin to modulate growth and differentiation factor 8 [GDF-8] and bone morphogenic protein 11 [BMP-11]
|
AU765214B2
(en)
*
|
1998-05-06 |
2003-09-11 |
Metamorphix International, Inc. |
Methods for treating diabetes by inhibiting gdf-8
|
US7147839B2
(en)
|
1998-05-29 |
2006-12-12 |
Curis, Inc. |
Methods for evaluating tissue morphogenesis and activity
|
WO2000004051A2
(en)
*
|
1998-07-15 |
2000-01-27 |
Metamorphix, Inc. |
Growth differentiation factor promoter and uses therefor
|
WO2000043781A2
(en)
*
|
1999-01-21 |
2000-07-27 |
Metamorphix, Inc. |
Growth differentiation factor inhibitors and uses therefor
|
US6727224B1
(en)
|
1999-02-01 |
2004-04-27 |
Genetics Institute, Llc. |
Methods and compositions for healing and repair of articular cartilage
|
DE19906096A1
(de)
|
1999-02-13 |
2000-08-17 |
Walter Sebald |
Protein mit einem Heparin-bindenden Epitop
|
US6284882B1
(en)
*
|
1999-06-10 |
2001-09-04 |
Abbott Laboratories |
Myostatin gene promoter and inhibition of activation thereof
|
AU4889100A
(en)
|
1999-07-30 |
2001-02-01 |
Pfizer Products Inc. |
Myostatin regulatory region, nucleotide sequence determination and methods for its use
|
US6756215B1
(en)
*
|
2000-10-20 |
2004-06-29 |
The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services |
Functionalized TGF-β fusion proteins
|
US7037501B2
(en)
*
|
2001-01-04 |
2006-05-02 |
Regents Of The University Of Minnesota |
Myostatin immnoconjugate
|
TWI329129B
(en)
|
2001-02-08 |
2010-08-21 |
Wyeth Corp |
Modified and stabilized gdf propeptides and uses thereof
|
KR100420798B1
(ko)
*
|
2001-02-10 |
2004-03-02 |
(주)알에이싸이언스 |
펩타이드 벡터
|
TWI267378B
(en)
|
2001-06-08 |
2006-12-01 |
Wyeth Corp |
Calcium phosphate delivery vehicles for osteoinductive proteins
|
US7320789B2
(en)
*
|
2001-09-26 |
2008-01-22 |
Wyeth |
Antibody inhibitors of GDF-8 and uses thereof
|
US6798160B2
(en)
*
|
2001-11-02 |
2004-09-28 |
Honda Giken Kogyo Kabushiki Kaisha |
Electric working machine
|
EP1572934A4
(de)
*
|
2002-02-21 |
2007-12-19 |
Wyeth Corp |
Proteine mit follistatindomäne
|
EP1572909A4
(de)
|
2002-02-21 |
2007-06-06 |
Wyeth Corp |
Protein mit follistatindomäne
|
EP2192129A1
(de)
*
|
2002-09-16 |
2010-06-02 |
Johns Hopkins University |
Metalloproteaseaktivierung von Myostatin sowie Verfahren zur Modulation der Myostatinaktivität
|
US7261893B2
(en)
|
2002-10-22 |
2007-08-28 |
Wyeth |
Neutralizing antibodies against GDF-8 and uses therefor
|
US20040223966A1
(en)
*
|
2002-10-25 |
2004-11-11 |
Wolfman Neil M. |
ActRIIB fusion polypeptides and uses therefor
|
EP2272864A3
(de)
|
2002-12-20 |
2011-02-16 |
Amgen Inc. |
Bindende Wirkstoffe zum Hemmen von Myostatin
|
CA2526669A1
(en)
|
2003-06-02 |
2004-12-16 |
Wyeth |
Use of myostatin (gdf8) inhibitors in conjunction with corticosteroids for treating neuromuscular disorders
|
EP1675608B1
(de)
|
2003-09-12 |
2007-03-21 |
Wyeth |
Injizierbare feste calciumphosphat-stäbe zur abgabe von osteogenen proteinen
|
JP2007535912A
(ja)
*
|
2003-12-31 |
2007-12-13 |
シェーリング−プラウ・リミテッド |
中和エピトープベースの増殖増強性ワクチン
|
CA2558395C
(en)
|
2004-03-10 |
2011-11-29 |
Scil Technology Gmbh |
Coated implants, their manufacturing and use thereof
|
MXPA06010929A
(es)
*
|
2004-03-23 |
2007-01-16 |
Lilly Co Eli |
Anticuerpos anti-miostatina.
|
JP4688483B2
(ja)
*
|
2004-04-15 |
2011-05-25 |
株式会社テクノネットワーク四国 |
フォリスタチン変異体ポリペプチド
|
US7575751B2
(en)
|
2004-04-27 |
2009-08-18 |
Research Development Foundation |
Activin-A mutants
|
WO2005115438A1
(en)
|
2004-05-25 |
2005-12-08 |
Stryker Corporation |
Use of morphogenic proteins for treating cartilage defects
|
US20060034831A1
(en)
*
|
2004-08-12 |
2006-02-16 |
Wyeth |
Combination therapy for diabetes, obesity and cardiovascular diseases using GDF-8 inhibitors
|
US7473678B2
(en)
|
2004-10-14 |
2009-01-06 |
Biomimetic Therapeutics, Inc. |
Platelet-derived growth factor compositions and methods of use thereof
|
AR051853A1
(es)
*
|
2004-12-30 |
2007-02-14 |
Schering Plough Ltd |
Vacuna para aumentar el crecimiento basada en epitopes neutralizantes
|
US20060166251A1
(en)
*
|
2005-01-26 |
2006-07-27 |
Archambault Joanne M |
Use of sFRPs as markers of BMP activity
|
CA2596506C
(en)
|
2005-02-09 |
2021-04-06 |
Avi Biopharma, Inc. |
Antisense composition and method for treating muscle atrophy
|
CN101137906A
(zh)
*
|
2005-03-23 |
2008-03-05 |
惠氏公司 |
对gdf-8调节剂的免疫应答的检测
|
EP1863518A2
(de)
*
|
2005-03-30 |
2007-12-12 |
Wyeth |
VERFAHREN ZUR STIMULATION DES WAARWACHSTUMS MITTELS VERABREICHUNG VON BMPs
|
DK1915397T3
(en)
|
2005-08-19 |
2015-04-20 |
Wyeth Llc |
Antagonist AGAINST GDF-8 AND USES IN TREATMENT OF ALS AND OTHER GDF-8-ASSOCIATED DISEASES
|
ES2533464T3
(es)
*
|
2005-10-06 |
2015-04-10 |
Eli Lilly And Company |
Anticuerpos anti-miostatina
|
UA92504C2
(en)
|
2005-10-12 |
2010-11-10 |
Эли Лилли Энд Компани |
Anti-myostatin monoclonal antibody
|
US8067562B2
(en)
|
2005-11-01 |
2011-11-29 |
Amgen Inc. |
Isolated nucleic acid molecule comprising the amino acid sequence of SEQ ID NO:1
|
US8147860B2
(en)
|
2005-12-06 |
2012-04-03 |
Etex Corporation |
Porous calcium phosphate bone material
|
MX2008007324A
(es)
*
|
2005-12-06 |
2009-03-04 |
Amgen Inc |
Usos de antagonistas de miostatina.
|
EP2311505B1
(de)
|
2006-02-09 |
2013-11-06 |
BioMimetic Therapeutics, LLC |
Zusammensetzungen und Verfahren zur Behandlung von Knochen
|
WO2007114319A1
(ja)
|
2006-03-31 |
2007-10-11 |
Chugai Seiyaku Kabushiki Kaisha |
抗体の血中動態を制御する方法
|
EP2035030A2
(de)
|
2006-05-17 |
2009-03-18 |
Stryker Corporation |
Verwendung löslicher morphogener proteinkomplexe zur behandlung von knorpeldefekten
|
US9161967B2
(en)
|
2006-06-30 |
2015-10-20 |
Biomimetic Therapeutics, Llc |
Compositions and methods for treating the vertebral column
|
US9642891B2
(en)
|
2006-06-30 |
2017-05-09 |
Biomimetic Therapeutics, Llc |
Compositions and methods for treating rotator cuff injuries
|
US8524265B2
(en)
|
2006-08-17 |
2013-09-03 |
Warsaw Orthopedic, Inc. |
Medical implant sheets useful for tissue regeneration
|
PL2066695T3
(pl)
|
2006-09-05 |
2013-08-30 |
Lilly Co Eli |
Przeciwciała przeciwko miostatynie
|
AU2007234612B2
(en)
|
2006-12-14 |
2013-06-27 |
Johnson & Johnson Regenerative Therapeutics, Llc |
Protein stabilization formulations
|
AU2007339280B2
(en)
|
2006-12-21 |
2013-12-05 |
Stryker Corporation |
Sustained-release formulations comprising crystals, macromolecular gels, and particulate suspensions of biologic agents
|
US8501678B2
(en)
|
2007-03-06 |
2013-08-06 |
Atara Biotherapeutics, Inc. |
Variant activin receptor polypeptides and uses thereof
|
US7947646B2
(en)
|
2007-03-06 |
2011-05-24 |
Amgen Inc. |
Variant activin receptor polypeptides
|
US8236751B2
(en)
*
|
2007-03-07 |
2012-08-07 |
The Johns Hopkins University |
Methods of increasing muscle mass using follistatin-like related gene (FLRG)
|
US7678764B2
(en)
|
2007-06-29 |
2010-03-16 |
Johnson & Johnson Regenerative Therapeutics, Llc |
Protein formulations for use at elevated temperatures
|
GB0715087D0
(en)
|
2007-08-03 |
2007-09-12 |
Summit Corp Plc |
Drug combinations for the treatment of duchenne muscular dystrophy
|
EP3251694A1
(de)
|
2007-08-03 |
2017-12-06 |
Summit (Oxford) Limited |
Wirkstoffkombinationen zur behandlung der duchenne-muskeldystrophie
|
EP2187932B1
(de)
|
2007-08-07 |
2015-01-28 |
DePuy Synthes Products, LLC |
Proteinformulierungen mit gdf-5 in wässriger saurer lösung
|
EP2202245B1
(de)
|
2007-09-26 |
2016-08-24 |
Chugai Seiyaku Kabushiki Kaisha |
Verfahren zum modifizieren des isoelektrischen punkts eines antikörpers durch aminosäuresubstitution in der cdr
|
US8741840B2
(en)
|
2008-02-13 |
2014-06-03 |
Washington University |
BMP-7 for use in treating neointimal hyperplasia
|
WO2009111793A2
(en)
|
2008-03-07 |
2009-09-11 |
Myoscience, Inc. |
Subdermal tissue remodeling using myostatin, methods and related systems
|
SI2275443T1
(sl)
|
2008-04-11 |
2016-03-31 |
Chugai Seiyaku Kabushiki Kaisha |
Antigen-vezavna molekula, ki se je sposobna ponovljivo vezati na dve ali več antigenskih molekul
|
WO2009129101A1
(en)
|
2008-04-14 |
2009-10-22 |
Advanced Technologies And Regenerative Medicine, Llc |
Liquid buffered gdf-5 formulations
|
BR122020000059B8
(pt)
|
2008-09-09 |
2021-06-22 |
Biomimetic Therapeutics Inc |
composição que compreende uma matriz biocompatível e um fator de crescimento derivado de plaqueta e kit
|
EA201100832A1
(ru)
|
2008-11-26 |
2011-12-30 |
Амген Инк. |
Варианты полипептидов рецептора iib активина и их применение
|
TW201029662A
(en)
|
2008-12-19 |
2010-08-16 |
Glaxo Group Ltd |
Novel antigen binding proteins
|
WO2010093925A2
(en)
|
2009-02-12 |
2010-08-19 |
Stryker Corporation |
PERIPHERAL ADMINISTRATION OF PROTEINS INCLUDING TGF-β SUPERFAMILY MEMBERS FOR TREATMENT OF SYSTEMIC DISORDERS AND DISEASE
|
EP2396026A2
(de)
|
2009-02-12 |
2011-12-21 |
Stryker Corporation |
Zusammensetzungen und verfahren für die minimal invasive systemische abgabe von proteinen einschliesslich mitglieder der tgf-superfamilie
|
US20120148539A1
(en)
|
2009-03-24 |
2012-06-14 |
Moulay Hicham Alaoui-Ismaili |
Methods and Compositions for Tissue Engineering
|
US8609127B2
(en)
|
2009-04-03 |
2013-12-17 |
Warsaw Orthopedic, Inc. |
Medical implant with bioactive material and method of making the medical implant
|
US20110002897A1
(en)
|
2009-06-11 |
2011-01-06 |
Burnham Institute For Medical Research |
Directed differentiation of stem cells
|
WO2011031856A1
(en)
|
2009-09-09 |
2011-03-17 |
Stryker Corporation |
Bmp -7 for use in treating pain induced by injuries and diseases of an articular joint
|
ES2387379T3
(es)
|
2009-09-17 |
2012-09-21 |
Stryker Corporation |
Tampones para controlar el pH de las proteínas morfogenéticas óseas
|
JP2013514811A
(ja)
|
2009-12-22 |
2013-05-02 |
ストライカー コーポレイション |
免疫原性が抑制されたbmp−7変異体
|
JP6144049B2
(ja)
|
2010-02-22 |
2017-06-07 |
バイオミメティック セラピューティクス,リミテッド ライアビリティ カンパニー |
腱障害を処置するための血小板由来成長因子組成物及び方法
|
JO3340B1
(ar)
|
2010-05-26 |
2019-03-13 |
Regeneron Pharma |
مضادات حيوية لـعامل تمايز النمو 8 البشري
|
AR081556A1
(es)
|
2010-06-03 |
2012-10-03 |
Glaxo Group Ltd |
Proteinas de union al antigeno humanizadas
|
MX2013001845A
(es)
|
2010-08-16 |
2013-08-27 |
Amgen Inc |
Polipetidos que enlazan miostatina, composiciones y metodos.
|
JP5985480B2
(ja)
|
2010-08-20 |
2016-09-06 |
ワイス・エルエルシー |
デザイナー骨形成タンパク質
|
US9688735B2
(en)
|
2010-08-20 |
2017-06-27 |
Wyeth Llc |
Designer osteogenic proteins
|
TWI654204B
(zh)
|
2010-11-30 |
2019-03-21 |
中外製藥股份有限公司 |
具有鈣依存性的抗原結合能力之抗體
|
US20130085139A1
(en)
|
2011-10-04 |
2013-04-04 |
Royal Holloway And Bedford New College |
Oligomers
|
US8871209B2
(en)
|
2011-11-14 |
2014-10-28 |
Regeneron Pharmaceuticals, Inc. |
Compositions and methods for increasing muscle mass and muscle strength by specifically antagonizing GDF8 and or Activin A
|
EA201491231A8
(ru)
|
2011-12-19 |
2015-01-30 |
Амген Инк. |
Варианты полипептидов рецептора активина и их применение
|
WO2013186719A1
(en)
|
2012-06-15 |
2013-12-19 |
Pfizer Inc. |
Improved antagonist antibodies against gdf-8 and uses therefor
|
US10034945B2
(en)
|
2012-07-13 |
2018-07-31 |
Trustees Of Tufts College |
Silk powder compaction for production of constructs with high mechanical strength and stiffness
|
WO2014039189A1
(en)
|
2012-08-01 |
2014-03-13 |
Mcnally Elizabeth |
Mitigating tissue damage and fibrosis via latent transforming growth factor beta binding protein (ltbp4)
|
JP6774164B2
(ja)
|
2012-08-24 |
2020-10-21 |
中外製薬株式会社 |
マウスFcγRII特異的Fc抗体
|
NZ705370A
(en)
|
2012-08-24 |
2018-06-29 |
Chugai Pharmaceutical Co Ltd |
Fcγriib-specific fc region variant
|
MY189682A
(en)
|
2012-09-13 |
2022-02-25 |
Bristol Myers Squibb Co |
Fibronectin based scaffold domain proteins that bind to myostatin
|
EA201591423A1
(ru)
|
2013-02-01 |
2016-01-29 |
Санта Мария Биотерапевтикс, Инк. |
Введение антитела к активину-а пациентам
|
EP3783017A1
(de)
|
2013-04-02 |
2021-02-24 |
Chugai Seiyaku Kabushiki Kaisha |
Varianten der fc-region
|
HUE052232T2
(hu)
|
2013-05-06 |
2021-04-28 |
Scholar Rock Inc |
Készítmények és eljárások növekedési faktor modulálására
|
TW201920262A
(zh)
|
2013-07-30 |
2019-06-01 |
美商再生元醫藥公司 |
抗活化素a之抗體及其用途
|
CA3005158A1
(en)
|
2014-11-06 |
2016-05-12 |
Scholar Rock, Inc. |
Anti-pro/latent-myostatin antibodies and uses thereof
|
WO2016073879A2
(en)
*
|
2014-11-06 |
2016-05-12 |
Scholar Rock, Inc. |
Transforming growth factor-related antibodies and uses thereof
|
KR101860280B1
(ko)
|
2014-12-19 |
2018-05-21 |
추가이 세이야쿠 가부시키가이샤 |
항-마이오스타틴 항체, 변이체 Fc 영역을 함유하는 폴리펩타이드, 및 사용 방법
|
KR20170110129A
(ko)
|
2015-02-05 |
2017-10-10 |
추가이 세이야쿠 가부시키가이샤 |
이온 농도 의존적 항원 결합 도메인을 포함하는 항체, Fc 영역 개변체, IL-8에 결합하는 항체, 및 그들의 사용
|
MA41795A
(fr)
|
2015-03-18 |
2018-01-23 |
Sarepta Therapeutics Inc |
Exclusion d'un exon induite par des composés antisens dans la myostatine
|
EP3283519A1
(de)
|
2015-04-15 |
2018-02-21 |
Regeneron Pharmaceuticals, Inc. |
Verfahren zur erhöhung der stärke und funktionalität mit gdf8-inhibitoren
|
KR20230155021A
(ko)
|
2015-09-15 |
2023-11-09 |
스칼러 락, 인크. |
항-프로/잠재성-미오스타틴 항체 및 그의 용도
|
MA45819A
(fr)
|
2015-10-09 |
2018-08-15 |
Sarepta Therapeutics Inc |
Compositions et méthodes pour traiter la dystrophie musculaire de duchenne et troubles associés
|
JP7025021B2
(ja)
|
2015-10-26 |
2022-02-24 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
還元多糖および酸化多糖ならびにそれらの使用の方法
|
EP3394098A4
(de)
|
2015-12-25 |
2019-11-13 |
Chugai Seiyaku Kabushiki Kaisha |
Anti-myostatin-antikörper und verfahren zur verwendung
|
CN115814077A
(zh)
*
|
2016-01-08 |
2023-03-21 |
供石公司 |
抗-原肌生长抑制素/潜伏肌生长抑制素抗体及其使用方法
|
US10946036B2
(en)
|
2016-06-13 |
2021-03-16 |
Scholar Rock, Inc. |
Use of myostatin inhibitors and combination therapies
|
KR102306744B1
(ko)
|
2016-06-17 |
2021-09-28 |
추가이 세이야쿠 가부시키가이샤 |
항-마이오스타틴 항체 및 사용 방법
|
WO2018025982A1
(ja)
|
2016-08-05 |
2018-02-08 |
中外製薬株式会社 |
Il-8関連疾患の治療用又は予防用組成物
|
ES2944357T3
(es)
|
2017-01-06 |
2023-06-20 |
Scholar Rock Inc |
Tratamiento de enfermedades metabólicas inhibiendo la activación de miostatina
|
CN111787981A
(zh)
|
2018-03-01 |
2020-10-16 |
瑞泽恩制药公司 |
改变身体组成的方法
|
US20220220213A1
(en)
|
2018-12-18 |
2022-07-14 |
Regeneron Pharmaceuticals, Inc. |
Compositions and Methods for Enhancing Body Weight and Lean Muscle Mass Using Antagonists Against Leptin Receptor, GDF8 and Activin A
|
CA3124415A1
(en)
|
2018-12-21 |
2020-06-25 |
Northwestern University |
Use of annexins in preventing and treating muscle membrane injury
|
WO2020139977A1
(en)
|
2018-12-26 |
2020-07-02 |
Northwestern University |
Use of glucocorticoid steroids in preventing and treating conditions of muscle wasting, aging and metabolic disorder
|
JP7375525B2
(ja)
*
|
2019-12-23 |
2023-11-08 |
株式会社島津製作所 |
患者認証システムおよび患者認証方法
|
JP7397822B2
(ja)
|
2021-05-14 |
2023-12-13 |
花王株式会社 |
口腔用貼付シート
|
WO2024064842A1
(en)
|
2022-09-21 |
2024-03-28 |
Regeneron Pharmaceuticals, Inc. |
Methods of treating obesity, diabetes, and liver dysfunction
|